Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

The future for Pharmacists is here

CHASE and Medacy will be in attendance at this year's Clinical Pharmacy Congress (CPC) on 12 - 13 May 2023 at the ExCeL Centre in London.

CHASE

- PMLiVE

CHASE and Medacy will be attending Clinical Pharmacy Congress 2023

CHASE and Medacy will be in attendance at this year's Clinical Pharmacy Congress (CPC) on 12 - 13 May 2023 at the ExCeL Centre in London.

CHASE

- PMLiVE

Caroline Pond joins CHASE as NHS Partnership Working Director

CHASE is delighted to welcome Caroline Pond as NHS Partnership Working Director.

CHASE

- PMLiVE

GSK welcomes Canadian court ruling to dismiss Zantac litigation

The company and other drugmakers have been facing thousands of lawsuits claiming ranitidine caused cancer

- PMLiVE

Amgen and TScan Therapeutics partner to identify new Crohn’s disease targets

Inflammatory bowel disease affects nearly one in every 100 people in the US

- PMLiVE

VMLY&R and KDog join forces in project to train abandoned dogs to become medical detection dogs

Dogs Without Borders is a unique project that trains abandoned dogs to become medical detection dogs that can diagnose people living in remote communities

Real-World Impact of Continuing Medical Education on Physician Behavior in Prevention of Migraine

During the Alliance For Continuing Education in the Health Professions Industry Summit Medscape Education was awarded a Best in Class designation for its use of Real-World Outcomes to measure the impact of...

Medscape Education

New syndicated reports now available

Living with CD, PsO, IPF & PF-ILD 2023

Inizio

Hyper-personalisation – The immediate future of pharma is personalised.

What does hyper-personalisation in Pharma look like?

Mednet

Train your brain for success

In this episode of Impetus Digital‘s Fireside Chat series, Natalie Yeadon, Co-Founder and CEO of Impetus Digital sits down with Max Newlon, President of Brain Co. They discuss everything from...

Impetus Digital

- PMLiVE

Sobi to acquire CTI BioPharma for approximately $1.7bn

The deal marks a notable expansion to the Swedish drugmaker's rare haematology pipeline

- PMLiVE

Novavax announces positive phase 2 results for COVID-19/influenza vaccine candidates

A combination COVID-19/influenza vaccine is included in the mid-stage study

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links